Biotricity Inc. (BTCY): Price and Financial Metrics

Biotricity Inc. (BTCY): $0.98

0.00 (0.10%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

BTCY Price/Volume Stats

Current price $0.98 52-week high $5.10
Prev. close $0.98 52-week low $0.70
Day low $0.96 Volume 17,600
Day high $1.04 Avg. volume 24,559
50-day MA $1.01 Dividend yield N/A
200-day MA $2.06 Market Cap 8.40M

BTCY Stock Price Chart Interactive Chart >

BTCY Stock Summary

  • BTCY has a market capitalization of $10,259,320 -- more than approximately just 5.46% of US stocks.
  • BIOTRICITY INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 6.38% of US listed stocks.
  • In terms of volatility of its share price, BTCY is more volatile than 94.84% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to BIOTRICITY INC are MARK, LIQT, LNN, ECOR, and ASYS.
  • BTCY's SEC filings can be seen here. And to visit BIOTRICITY INC's official web site, go to www.biotricity.com.

BTCY Valuation Summary

  • BTCY's price/sales ratio is 0.9; this is 59.09% lower than that of the median Healthcare stock.
  • BTCY's EV/EBIT ratio has moved up 9.8 over the prior 71 months.

Below are key valuation metrics over time for BTCY.

Stock Date P/S P/B P/E EV/EBIT
BTCY 2023-12-29 0.9 -0.4 -0.6 -2.3
BTCY 2023-12-28 1.0 -0.4 -0.6 -2.4
BTCY 2023-12-27 1.1 -0.4 -0.7 -2.5
BTCY 2023-12-26 1.1 -0.5 -0.7 -2.5
BTCY 2023-12-22 0.9 -0.4 -0.6 -2.3
BTCY 2023-12-21 0.9 -0.4 -0.6 -2.3

BTCY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BTCY has a Quality Grade of D, ranking ahead of 17.94% of graded US stocks.
  • BTCY's asset turnover comes in at 1.211 -- ranking 13th of 186 Medical Equipment stocks.
  • BDX, MYO, and DXCM are the stocks whose asset turnover ratios are most correlated with BTCY.

The table below shows BTCY's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.211 0.571 9.723
2021-03-31 1.039 0.447 20.815
2020-12-31 0.739 0.532 -366.209
2020-09-30 0.636 0.475 38.103
2020-06-30 0.663 0.446 61.574
2020-03-31 0.588 0.488 18.057

BTCY Price Target

For more insight on analysts targets of BTCY, see our BTCY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.50 Average Broker Recommendation 1.5 (Moderate Buy)

Biotricity Inc. (BTCY) Company Bio


Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It also involves in delivering, remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. The firm’s FDA-approved Bioflux MCT technology, is comprised of a monitoring device and software components, which is made available to the market, in order to assess, establish and develop sales processes, and market dynamics. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.


BTCY Latest News Stream


Event/Time News Detail
Loading, please wait...

BTCY Latest Social Stream


Loading social stream, please wait...

View Full BTCY Social Stream

Latest BTCY News From Around the Web

Below are the latest news stories about BIOTRICITY INC that investors may wish to consider to help them evaluate BTCY as an investment opportunity.

Biotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call Transcript

Biotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call Transcript November 14, 2023 Operator: Good afternoon, and welcome to Biotricity’s Second Quarter Fiscal 2024 Financial Results and Business Update Conference Call. Today’s conference is being recorded. And at this time, I would like to turn the conference over to Debra Chen with Investor Relations. Please go ahead, […]

Yahoo | November 16, 2023

Biotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024

Company reports Q2-FY24 revenue grew by 21.4% YOY to $2.9 million; continuing to advance toward positive cashflowRecurring technology fees, customer device sales, remain on an upward trendReduced SG&A to $3.5 million, down 22% compared to same period ...

Yahoo | November 14, 2023

Biotricity to Host Second Quarter Fiscal Year 2024 Financial Results and Business Update Call on November 14th

Biotricity improves margins while lowering selling expenses and operating lossesREDWOOD CITY, CA / ACCESSWIRE / November 10, 2023 / Biotricity Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in ...

Yahoo | November 10, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time for another dive into the biggest pre-market stock movers as we break down all of the latest news for Tuesday morning.

William White on InvestorPlace | November 7, 2023

Biotricity Releases Another Groundbreaking Product: Biotres Pro

Company further expands its current product portfolio, making it the most comprehensive Remote Patient and Cardiac Monitoring portfolio globally.Company developed Biotres Pro with critical capability of cellular backup for connectivityRecently filed ...

Yahoo | October 31, 2023

Read More 'BTCY' Stories Here

BTCY Price Returns

1-mo 11.49%
3-mo 3.16%
6-mo -53.11%
1-year -77.00%
3-year -93.59%
5-year -79.84%
YTD -14.78%
2023 -57.22%
2022 -88.74%
2021 439.08%
2020 17.17%
2019 31.27%

Continue Researching BTCY

Want to see what other sources are saying about Biotricity Inc's financials and stock price? Try the links below:

Biotricity Inc (BTCY) Stock Price | Nasdaq
Biotricity Inc (BTCY) Stock Quote, History and News - Yahoo Finance
Biotricity Inc (BTCY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!